Results 151 to 160 of about 42,730 (222)

Pyrazole-Cyclotriphosphazene Hybrids: Synthesis, Structural Insights, and Cytotoxic Effects against Pancreatic Cancer Cells. [PDF]

ACS Omega
Mutlu Balcı C, Dalbayrak B, Mutlu E, Palabıyık D, Arısan ED.   +4 more
europepmc   +1 more source

Repurposing Rilmenidine as a Potential Antimetastatic Therapy Targeting Nischarin in Pancreatic Ductal Adenocarcinoma. [PDF]

Cells
Živić K, Pavlović M, Ostojić M, Galun D, Pavić A, Srdić-Rajić T, Grahovac J.   +6 more
europepmc   +1 more source

ALKBH5/IGF2BP1-mediated m⁶A demethylation of TRIM37 promotes pancreatic cancer tumorigenesis and glycolysis by mediating RBMX degradation. [PDF]

Cell Biol Toxicol
Yan C, Li X, Zhao Y, Chen J, Peng X, Wu D, Chang Y, Chen G.   +7 more
europepmc   +1 more source

Oroxylin A Directly Targets SRC to Inhibit the PI3K/AKT Signaling Axis in Pancreatic Cancer: An Integrated Bioinformatics and Experimental Study. [PDF]

Biomolecules
Zhang J, Song M, Liu H, Zhang Y, Zhang Y, Guan Z, Zhang S, Wang J, Zhang S, Lv Y.   +9 more
europepmc   +1 more source

Kaempferol Inhibits MMP-1-Mediated Migration and Invasion in Gemcitabine-Resistant Pancreatic Cancer Cells. [PDF]

Nutrients
Sugita S, Matsuo Y, Ishida M, Uehara Y, Eguchi Y, Denda Y, Nonoyama K, Murase H, Kato T, Saito K, Sato T, Yamakawa Y, Sagawa H, Ogawa R, Takahashi H, Mitsui A, Takiguchi S.   +16 more
europepmc   +1 more source

<i>BIRC5</i> Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 Expression. [PDF]

Int J Nanomedicine
Chang YC, Huang WL, Su WC, Leung E, Cheng FY, Cheung CHA.   +5 more
europepmc   +1 more source

Correction: Osthole induces accumulation of impaired autophagosome against pancreatic cancer cells. [PDF]

Sci Rep
Weng N, Lv S, Chen H, Zheng H, Lin T, Zhu Q, Zhu K, Huang S.   +7 more
europepmc   +1 more source

GelMA Versus Agarose Hydrogels in Pancreatic Cancer 3D Spheroid Modeling: Effects on Morphology, HIF-1α Expression, and Gemcitabine Response. [PDF]

Gels
Celik Z, Gumushan Aktas H, Aktas B, Yalcin S.   +3 more
europepmc   +1 more source

Gemcitabine-induced β4 integrin drives cancer progression and gemcitabine resistance in pancreatic cancer. [PDF]

J Exp Clin Cancer Res
Kariya Y, Suzuki H, Kariya Y, Nishita M.
europepmc   +1 more source

A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking Annexin A1. [PDF]

Cells
Belvedere R, Novizio N, Ruggiero D, Palazzo M, Bruno I, Terracciano S, Petrella A.   +6 more
europepmc   +1 more source